First Trust Advisors LP Exelixis, Inc. Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

A detailed history of First Trust Advisors LP transactions in Exelixis, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 2,868,617 shares of EXEL stock, worth $95.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,868,617

Previous 2,586,267 10.92%

Holding current value

$95.5 Million

Previous $58.1 Million 28.1%

% of portfolio

0.07%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.96 - $27.6 $6.2 Million - $7.79 Million	282,350 Added 10.92%	2,868,617 $74.4 Million
Q2 2024 Aug 13, 2024	SELL	$20.34 - $23.73 $7.88 Million - $9.19 Million	-387,315 Reduced 13.03%	2,586,267 $58.1 Million
Q1 2024 May 13, 2024	SELL	$20.17 - $23.93 $3.61 Million - $4.29 Million	-179,173 Reduced 5.68%	2,973,582 $70.6 Million
Q4 2023 Feb 13, 2024	BUY	$19.25 - $24.13 $9.48 Million - $11.9 Million	492,613 Added 18.52%	3,152,755 $75.6 Million
Q3 2023 Nov 13, 2023	SELL	$19.04 - $22.74 $26.6 Million - $31.7 Million	-1,395,960 Reduced 34.42%	2,660,142 $58.1 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $12.7 Million - $14.3 Million	-696,632 Reduced 14.66%	4,056,102 $77.5 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $15.1 Million - $17.9 Million	924,189 Added 24.14%	4,752,734 $92.3 Million
Q4 2022 Feb 09, 2023	BUY	$14.96 - $17.39 $2.73 Million - $3.17 Million	182,299 Added 5.0%	3,828,545 $61.4 Million
Q3 2022 Nov 14, 2022	BUY	$15.68 - $22.27 $6.02 Million - $8.55 Million	384,054 Added 11.77%	3,646,246 $57.2 Million
Q2 2022 Aug 12, 2022	SELL	$17.44 - $23.16 $5.23 Million - $6.95 Million	-300,161 Reduced 8.43%	3,262,192 $67.9 Million
Q1 2022 May 13, 2022	BUY	$17.03 - $22.67 $14.2 Million - $18.9 Million	835,621 Added 30.65%	3,562,353 $80.8 Million
Q4 2021 Feb 08, 2022	SELL	$15.84 - $21.88 $15.1 Million - $20.9 Million	-955,947 Reduced 25.96%	2,726,732 $49.8 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $8.38 Million - $10.9 Million	513,866 Added 16.22%	3,682,679 $77.9 Million
Q2 2021 Aug 16, 2021	SELL	$17.95 - $25.56 $6.09 Million - $8.67 Million	-339,161 Reduced 9.67%	3,168,813 $57.7 Million
Q1 2021 May 14, 2021	BUY	$20.53 - $25.22 $3.26 Million - $4.01 Million	158,831 Added 4.74%	3,507,974 $79.2 Million
Q4 2020 Feb 02, 2021	SELL	$18.39 - $24.8 $11.4 Million - $15.4 Million	-619,460 Reduced 15.61%	3,349,143 $67.2 Million
Q3 2020 Nov 05, 2020	SELL	$20.67 - $26.94 $7.5 Million - $9.77 Million	-362,635 Reduced 8.37%	3,968,603 $97 Million
Q2 2020 Jul 22, 2020	SELL	$16.46 - $27.42 $10.5 Million - $17.4 Million	-635,902 Reduced 12.8%	4,331,238 $103 Million
Q1 2020 May 06, 2020	BUY	$14.46 - $21.8 $8.23 Million - $12.4 Million	568,921 Added 12.94%	4,967,140 $85.5 Million
Q4 2019 Feb 03, 2020	BUY	$15.15 - $18.89 $5.65 Million - $7.05 Million	373,013 Added 9.27%	4,398,219 $77.5 Million
Q3 2019 Nov 04, 2019	SELL	$17.68 - $22.65 $32.5 Million - $41.7 Million	-1,840,431 Reduced 31.38%	4,025,206 $71.2 Million
Q2 2019 Jul 30, 2019	BUY	$18.93 - $24.75 $8.2 Million - $10.7 Million	433,202 Added 7.97%	5,865,637 $125 Million
Q1 2019 May 09, 2019	SELL	$19.6 - $24.76 $2.33 Million - $2.94 Million	-118,703 Reduced 2.14%	5,432,435 $129 Million
Q4 2018 Feb 07, 2019	BUY	$13.65 - $21.8 $12.4 Million - $19.8 Million	907,412 Added 19.54%	5,551,138 $109 Million
Q3 2018 Oct 25, 2018	BUY	$15.87 - $22.4 $32.4 Million - $45.8 Million	2,044,201 Added 78.64%	4,643,726 $82.3 Million
Q2 2018 Aug 02, 2018	BUY	$18.56 - $22.45 $32 Million - $38.8 Million	1,726,507 Added 197.76%	2,599,525 $55.9 Million
Q1 2018 Apr 23, 2018	BUY	$22.15 - $31.89 $5.26 Million - $7.57 Million	237,256 Added 37.32%	873,018 $19.3 Million
Q4 2017 Feb 08, 2018	SELL	$24.23 - $30.93 $10.9 Million - $13.9 Million	-450,373 Reduced 41.47%	635,762 $19.3 Million
Q3 2017 Oct 24, 2017	BUY	$23.35 - $29.24 $25.4 Million - $31.8 Million	1,086,135	1,086,135 $26.3 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account

First Trust Advisors LP Exelixis, Inc. Transaction History